溶血性贫血

Go RS, Winters JL, Kay NE. How I treat autoimmune hemolytic anemia. Blood. 2017 Jun 1;129(22):2971-9 摘要

Hill QA, Stamps R, Massey E, et al. The diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol. 2017 Feb;176(3):395-411.全文  摘要

Hill QA, Stamps R, Massey E, et al. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. Br J Haematol. 2017 Apr;177(2):208-20.全文  摘要

1. Kim Y, Park J, Kim M. Diagnostic approaches for inherited hemolytic anemia in the genetic era. Blood Res. 2017 Jun;52(2):84-94.全文  摘要

2. Jung HL. A new paradigm in the diagnosis of hereditary hemolytic anemia. Blood Res. 2013 Dec;48(4):237-9.全文  摘要

3. Nkhoma ET, Poole C, Vannappagari V, et al. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009 May-Jun;42(3):267-78.全文  摘要

4. Lippi G, Mattiuzzi C. Updated worldwide epidemiology of inherited erythrocyte disorders. Acta Haematol. 2020;143(3):196-203. 摘要

5. Beutler E. Red cell enzyme defects. Hematol Pathol. 1990;4(3):103-14. 摘要

6. Heller P, Best WR, Nelson RB, et al. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med. 1979 May 3;300(18):1001-5. 摘要

7. Prchal JT, Gregg XT. Red cell enzymes. Hematology Am Soc Hematol Educ Program. 2005 Jan 1;1:19-23.全文  摘要

8. Barcellini W, Fattizzo B. How I treat warm autoimmune hemolytic anemia. Blood. 2021 Mar 11;137(10):1283-94.全文  摘要

9. Tranekær S, Hansen DL, Frederiksen H. Epidemiology of secondary warm autoimmune haemolytic anaemia: a systematic review and meta-analysis. J Clin Med. 2021 Mar 17;10(6):1244.全文  摘要

10. Go RS, Winters JL, Kay NE. How I treat autoimmune hemolytic anemia. Blood. 2017 Jun 1;129(22):2971-9 摘要

11. Kalfa TA. Warm antibody autoimmune hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):690-7.全文  摘要

12. Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2009 Jan 1;1:73-9.全文  摘要

13. Durán S, Apte M, Alarcón GS, et al. Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort. Arthritis Rheum. 2008 Sep 15;59(9):1332-40.全文  摘要

14. Giannini S, Martes C. Anemia in inflammatory bowel disease. Minerva Gastroenterol Dietol. 2006 Sep;52(3):275-91. 摘要

15. Sallah S, Sigounas G, Vos P, et al. Autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma: characteristics and significance. Ann Oncol. 2000 Dec;11(12):1571-7.全文  摘要

16. Autore F, Pasquale R, Innocenti I, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: a comprehensive review. Cancers (Basel). 2021 Nov 19;13(22):5804.全文  摘要

17. Hodgson K, Ferrer G, Montserrat E, et al. Chronic lymphocytic leukemia and autoimmunity: a systematic review. Haematologica. 2011 May;96(5):752-61.全文  摘要

18. Zhou JC, Wu MQ, Peng ZM, et al. Clinical analysis of 20 patients with non-Hodgkin lymphoma and autoimmune hemolytic anemia: a retrospective study. Medicine (Baltimore). 2020 Feb;99(7):e19015.全文  摘要

19. Ravindran A, Sankaran J, Jacob EK, et al. High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia. Am J Hematol. 2017 Aug;92(8):E164-6.全文  摘要

20. Palatianos GM, Laczkovics AM, Simon P, et al. Multicentered European study on safety and effectiveness of the On-X prosthetic heart valve: intermediate follow-up. Ann Thorac Surg. 2007 Jan;83(1):40-6.全文  摘要

21. Bavaria JE, Desai ND, Cheung A, et al. The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study. J Thorac Cardiovasc Surg. 2014 Feb;147(2):590-7.全文  摘要

22. Alkhouli M, Farooq A, Go RS, et al. Cardiac prostheses-related hemolytic anemia. Clin Cardiol. 2019 Jul;42(7):692-700.全文  摘要

23. Steensma DP, Hoyer JD, Fairbanks VF. Hereditary red blood cell disorders in middle eastern patients. Mayo Clin Proc. 2001 Mar;76(3):285-93. 摘要

24. Ryan K, Bain BJ, Worthington D, et al. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010 Apr;149(1):35-49.全文  摘要

25. Parker CJ. Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):208-16.全文  摘要

26. Berentsen S, Barcellini W. Autoimmune hemolytic anemias. N Engl J Med. 2021 Oct 7;385(15):1407-19. 摘要

27. Boilève A, Gavaud A, Grignano E, et al. Acute and fatal cephalosporin-induced autoimmune haemolytic anaemia. Br J Clin Pharmacol. 2021 Apr;87(4):2152-2156.全文  摘要

28. Lee SW, Chaiyakunapruk N, Lai NM. What G6PD-deficient individuals should really avoid. Br J Clin Pharmacol. 2017 Jan;83(1):211-2.全文  摘要

29. Telford RD, Sly GJ, Hahn AG, et al. Footstrike is the major cause of hemolysis during running. J Appl Physiol (1985). 2003 Jan;94(1):38-42.全文  摘要

30. Mintzer DM, Billet SN, Chmielewski L. Drug-induced hematologic syndromes. Adv Hematol. 2009;2009:495863.全文  摘要

31. Jang HN, Bae EJ, Hwang K, et al. Hemolytic uremic syndrome associated with paraquat intoxication. J Clin Apher. 2014 Jun;29(3):183-6. 摘要

32. White NJ. Anaemia and malaria. Malar J. 2018 Oct 19;17(1):371.全文  摘要

33. Rajapakse P, Bakirhan K. Autoimmune hemolytic anemia associated with human babesiosis. J Hematol. 2021 Apr;10(2):41-5.全文  摘要

34. Hubl W, Mostbeck B, Hartleb H, et al. Investigation of the pathogenesis of massive hemolysis in a case of Clostridium perfringens septicemia. Ann Hematol. 1993 Sep;67(3):145-7. 摘要

35. Hashiba M, Tomino A, Takenaka N, et al. Clostridium perfringens infection in a febrile patient with severe hemolytic anemia. Am J Case Rep. 2016 Apr 6;17:219-23.全文  摘要

36. Shurin SB, Anderson P, Zollinger J, et al. Pathophysiology of hemolysis in infections with Haemophilus influenzae type b. J Clin Invest. 1986 Apr;77(4):1340-8.全文  摘要

37. Hill QA, Stamps R, Massey E, et al. The diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol. 2017 Feb;176(3):395-411.全文  摘要

38. Jäger U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting. Blood Rev. 2020 May;41:100648. 摘要

39. Williams JD, Jayaprakash RK, Kithany H, et al. How to use Donath-Landsteiner test to diagnose paroxysmal cold haemoglobinuria (PCH). Arch Dis Child Educ Pract Ed. 2022 Jun;107(3):199-206.全文  摘要

40. Liesveld JL, Rowe JM, Lichtman MA. Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood. 1987 Mar;69(3):820-6.全文  摘要

41. Bain BJ. Diagnosis from the blood smear. N Engl J Med. 2005 Aug 4;353(5):498-507. 摘要

42. Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA. 1980 May 16;243(19):1909-11. 摘要

43. Galen RS. Application of the predictive value model in the analysis of test effectiveness. Clin Lab Med. 1982 Dec;2(4):685-99. 摘要

44. Oppenheim A, Jury CL, Rund D, et al. G6PD Mediterranean accounts for the high prevalence of G6PD deficiency in Kurdish Jews. Hum Genet. 1993 Apr;91(3):293-4. 摘要

45. Reynaud Q, Durieu I, Dutertre M, et al. Efficacy and safety of rituximab in auto-immune hemolytic anemia: a meta-analysis of 21 studies. Autoimmun Rev. 2015 Apr;14(4):304-13. 摘要

46. Liu AP, Cheuk DK. Disease-modifying treatments for primary autoimmune haemolytic anaemia. Cochrane Database Syst Rev. 2021 Mar 26;3(3):CD012493.全文  摘要

47. Bussone G, Ribeiro E, Dechartres A, et al. Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases. Am J Hematol. 2009 Mar;84(3):153-7.全文  摘要

48. Hill QA, Stamps R, Massey E, et al. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. Br J Haematol. 2017 Apr;177(2):208-20.全文  摘要

49. Salama A. Drug-induced immune hemolytic anemia. Expert Opin Drug Saf. 2009 Jan;8(1):73-9. 摘要

50. Scully M, Cataland S, Coppo P, et al. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost. 2017 Feb;15(2):312-22.全文  摘要

51. Zheng XL, Vesely SK, Cataland SR, et al. ISTH guidelines for treatment of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020 Oct;18(10):2496-502.全文  摘要

52. Martí-Carvajal AJ, Anand V, Cardona AF, et al. Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria. Cochrane Database Syst Rev. 2014 Oct 30;(10):CD010340.全文  摘要

53. Habermalz B, Sauerland S, Decker G, et al. Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2008 Apr;22(4):821-48. 摘要

54. Cai Y, Liu Z, Liu X. Laparoscopic versus open splenectomy for portal hypertension: a systematic review of comparative studies. Surg Innov. 2014 Aug;21(4):442-7. 摘要

55. Zheng X, Dou C, Yao Y, et al. A meta-analysis study of laparoscopic versus open splenectomy with or without esophagogastric devascularization in the management of liver cirrhosis and portal hypertension. J Laparoendosc Adv Surg Tech A. 2015 Feb;25(2):103-11. 摘要

56. Iolascon A, Andolfo I, Barcellini W, et al. Recommendations regarding splenectomy in hereditary hemolytic anemias. Haematologica. 2017 Aug;102(8):1304-13.全文  摘要

57. Recht J, Chansamouth V, White NJ, et al. Nitrofurantoin and glucose-6-phosphate dehydrogenase deficiency: a safety review. JAC Antimicrob Resist. 2022 Jun;4(3):dlac045.全文  摘要

58. Belfield KD, Tichy EM. Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency. Am J Health Syst Pharm. 2018 Feb 1;75(3):97-104. 摘要

59. Grace RF, Barcellini W. Management of pyruvate kinase deficiency in children and adults. Blood. 2020 Sep 10;136(11):1241-9.全文  摘要

60. Al-Samkari H, Galactéros F, Glenthøj A, et al. Mitapivat versus placebo for pyruvate kinase deficiency. N Engl J Med. 2022 Apr 14;386(15):1432-42. 摘要

61. Glenthøj A, van Beers EJ, Al-Samkari H, et al. Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial. Lancet Haematol. 2022 Oct;9(10):e724-32. 摘要

62. Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;1(1):CD007798.全文  摘要

63. Meyer O, Stahl D, Beckhove P, et al. Pulsed high-dose dexamethasone in chronic autoimmune haemolytic anaemia of warm type. Br J Haematol. 1997 Sep;98(4):860-2. 摘要

64. Röth A, Barcellini W, D'Sa S, et al. Sutimlimab in cold agglutinin disease. N Engl J Med. 2021 Apr 8;384(14):1323-34.全文  摘要

65. Flores G, Cunningham-Rundles C, Newland AC, et al. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients. Am J Hematol. 1993 Dec;44(4):237-42. 摘要

66. Shah FT, Porter JB, Sadasivam N, et al. Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias. Br J Haematol. 2022 Jan;196(2):336-50.全文  摘要

67. Barcellini W, Fattizzo B, Zaninoni A, et al. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood. 2014 Nov 6;124(19):2930-6.全文  摘要

68. Barcellini W, Zaninoni A, Fattizzo B, et al. Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers. Am J Hematol. 2018 Sep;93(9):E243-6.全文  摘要

69. Hoffman PC. Immune hemolytic anemia - selected topics. Hematology Am Soc Hematol Educ Program. 2009:80-6.全文  摘要